Feature|Articles|November 11, 2023
- Pharmaceutical Executive: November 2023
- Volume 43
- Issue 11
Pharmaceutical Executive: November 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive November 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 3 years ago
2024 Pipeline Report: First-World Focusalmost 3 years ago
Pharma Should Embrace the Single Sign-Onalmost 3 years ago
22nd Annual Industry Audit: The Pharma Value Picturealmost 3 years ago
Changing the Paradigm in AI Implementationalmost 3 years ago
Reading the Tea Leaves for Biotech As 2024 Approachesalmost 3 years ago
Pharma Giving is Still Strong Despite Post-Pandemic Shiftsalmost 3 years ago
Equity for Women in Healthcare: 131 Years is Too Long to Waitalmost 3 years ago
A Peek at PotentialAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
3
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
4
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
5